A rich R&D pipeline of second-wave DAAs could build on that achievement, with even more impressive efficacy, shorter treatment durations and better coverage of all hepatitis C genotypes.

Before starting treatment, you need to take a simple blood test to learn which genotype you have. Some DAAs can be used to treat all hepatitis C genotypes. Effective direct-acting antiviral or 'DAA' ...

Approved earlier this year, Gilead's Epclusa was the first combination to treat all six major hepatitis C genotypes. In hepatitis C, Gilead is becoming a victim of its own success, as many ...

Israel to fight on in Gaza for 'as long as the hostages are not returned': minister Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, ...

Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously ...

The Hepatitis C virus (HCV) is one of the most common forms of viral hepatitis in the UK. It can cause liver scarring (cirrhosis), liver cancer and failure of the liver. The virus has evolved into ...